ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 618939 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 618939; 2) Community: the network communities that were significantly associated with the response to NSC 618939; 3) Molecule: the relationships between components within communities and NSC 618939; 4) MDR: the compounds that were significantly associated with the NSC 618939.

NSC Compound Enrichment Correlation
NSC 606985 Camptothecin Derivative 2.27497142702985e-006 0.9119361
NSC 725774 6-[3-(Bis-hydroxyethylamino)-1-propyl]-5,6-dihydro-2,3-~ dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 2.27497142702985e-006 0.7000794
NSC 735037 Camptothecin Derivative 2.27497142702985e-006 0.87006008
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 2.27497142702985e-006 0.82308943
NSC 726332 6-[3-((2,2-Dimethoxyethylamino)-1-propyl)]-5,6-dihydro-2,3- dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c] isoquinoline 2.27718602463644e-005 0.63922335
NSC 725775 6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 2.91688949446226e-008 0.72401753
NSC 697726 RH1 3.39349009784534e-005 0.74003236
NSC 375162 Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide 3.39349009784536e-005 0.35720062
NSC 638199 Null 3.40252996142932e-005 0.47420344
NSC 677169 Null 3.40252996142932e-005 0.52604166
Total:119  Current:117    [First] [Prev] [Next] [Last]